Get the Stockscreener App
0.4305
5.18%
-0.0235
Pre-market:
.35
-0.0805
-18.70%
Cellyan Biotechnology Co Ltd stock is traded at $0.4305, with a volume of 3.15M.
It is down -5.18% in the last 24 hours and down -7.12% over the past month.
Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
See More
Previous Close:
$0.454
Open:
$0.438
24h Volume:
3.15M
Relative Volume:
8.37
Market Cap:
$10.12M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-4.97%
1M Performance:
-7.12%
6M Performance:
-46.09%
1Y Performance:
-68.80%
1-Day Range:
$0.36
$0.438
1-Week Range:
$0.36
$0.49
52-Week Range:
$0.3176
$2.58
Cellyan Biotechnology Co Ltd Stock (HKPD) Company Profile
Name
Cellyan Biotechnology Co Ltd
Sector
Industry
Phone
-
Address
-
Compare HKPD vs MCK, COR, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HKPD
Cellyan Biotechnology Co Ltd
|
0.4305 | 10.12M | 0 | 0 | 0 | 0.00 |
MCK
Mckesson Corp
|
841.31 | 98.50B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
307.99 | 59.92B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
228.72 | 53.57B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
88.26 | 10.05B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.56 | 1.34B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cellyan Biotechnology Co Ltd Stock (HKPD) Latest News
Cellyan Biotechnology Stock Sinks 21% After Hours: Here's What Happened - Benzinga
12 Industrials Stocks Moving In Thursday's After-Market Session - Benzinga
Cellyan Biotechnology granted Nasdaq compliance extension; shares surge - MSN
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period - The Manila Times
Cellyan Biotechnology gets 180-day extension for Nasdaq compliance - Investing.com
Cellyan Biotechnology Receives Nasdaq Extension to Regain Minimum Bid Price Compliance - Quiver Quantitative
Nasdaq grants Cellyan Biotechnology (Nasdaq: HKPD) bid-price extension - Stock Titan
Cellyan Biotechnology Must Reach $1 Bid Price by Jan. 11 - Stock Titan
12 Industrials Stocks Moving In Wednesday's Intraday Session - Benzinga
12 Industrials Stocks Moving In Tuesday's Pre-Market Session - Benzinga
[EFFECT] Cellyan Biotechnology Co., Ltd SEC Filing - Stock Titan
Cellyan Biotechnology (HKPD) Slides 3.78% to $0.40 as Biotech Volatility PersistsInsider Selling Alerts - dars.gov.et
Cellyan Biotech (HKPD) Slides 7.6%, Testing Key Support at $0.39Channel Projection - newsline.com
Cellyan Biotechnology (NASDAQ: HKPD) files $200M shelf to sell shares, debt - Stock Titan
Cellyan Biotechnology (HKPD) director CHAN Kam Leung files initial Form 3 - Stock Titan
12 Industrials Stocks Moving In Wednesday's After-Market Session - Benzinga
[Form 3] Cellyan Biotechnology Co., Ltd Initial Statement of Beneficial Ownership - Stock Titan
12 Industrials Stocks Moving In Tuesday's Intraday SessionBimergen Energy (AMEX:BESS), EHang Holdings - Benzinga
Cellyan Biotechnology (HKPD) Chief Strategy Officer listed with no Form 3 transactions - Stock Titan
Cellyan Biotechnology (HKPD) CFO Liu Shu files initial ownership Form 3 - Stock Titan
Cellyan Biotechnology (HKPD) director Zhou Mike Yao files initial Form 3 - Stock Titan
Cellyan Biotechnology (HKPD) director Wu Jingyan submits initial SEC Form 3 - Stock Titan
Cellyan Biotechnology (HKPD) CEO and director files Form 3 with no share transactions - Stock Titan
Cellyan Biotechnology (HKPD) Slumps 7.83%: Key Support at $0.50 Under PressureFibonacci Fan - The Legal Advocate
Cellyan Biotechnology (HKPD) Holds Steady Near Support After Marginal GainsAdvance Decline Volume - The Legal Advocate
HKPDCellyan Biotechnology Co Ltd Stock Price and Quote - Finviz
Cellyan Biotechnology (HKPD) Drops 3.6% as Shares Approach Critical $0.50 SupportButterfly Setup - The Legal Advocate
Cellyan Biotechnology Faces Resistance at $0.57 After Recent DeclineDark Pool Prints - dars.gov.et
12 Industrials Stocks Moving In Wednesday's Pre-Market SessionBrenmiller Energy (NASDAQ:BNRG), Smart P - Benzinga
Cellyan (HKPD) quarterly earnings report shows no revenue, EPS data available amid biotechnology sector headwinds.Shared Buy Zones - Newser
What net volume Cellyan (HKPD)? (Smart Money Outflows) 2026-04-29Buy Signals - newser.com
What leverage Cellyan (HKPD)? | HKPD Latest Quarter Earnings: Cellyan logs zero revenue, advances key drug pipeline progressSocial Trading Insights - newser.com
HKPD Latest Quarter Earnings: Cellyan logs zero revenue, advances key drug pipeline progressPretax Income Report - The Legal Advocate
12 Industrials Stocks Moving In Friday's Pre-Market Session - Benzinga
HKPD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
HKPD (Cellyan) posts 21.7 percent Q2 2025 revenue growth, shares drop 6.58 percent amid negative earnings.Dividend Increase Stocks - The Legal Advocate
Cellyan (HKPD) Stock: Is It Ready for Entry (Institutional Demand) 2026-04-18Index Investing - Cổng thông tin điện tử tỉnh Lào Cai
HKPD Technical Analysis & ETF Price Forecast - Intellectia AI
HKPD Stock Analysis: Cellyan Biotechnology Co. Ltd gains 1.59% to trade at 0.57 dollar - newsline.com
12 Industrials Stocks Moving In Monday's Intraday Session - Benzinga
According to the latest documents disclosed by the U.S. Securities and Exchange Commission (SEC), the selling shareholders of Cellyan Biotechnology Co Ltd may sell up to 12.5 million Class A ordinary shares from time to time in the future. - Bitget
12.5M shares for resale — Cellyan Biotechnology (NASDAQ: HKPD) - stocktitan.net
Cellyan Biotechnology (HKPD) completes $6.5M private unit financing - Stock Titan
If You Invested $1,000 in Cellyan Biotechnology Co Ltd (HKPD) - Stock Titan
Cellyan Biotechnology Reports Lower Revenue and Profit in Latest Interim Results - TipRanks
Cellyan Biotechnology (HKPD) interim revenue and profit drop sharply in 2025 - Stock Titan
Cellyan Biotechnology Co., Ltd Reports Earnings Results for the Half Year Ended September 30, 2025 - marketscreener.com
HKPD Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
12 Industrials Stocks Moving In Tuesday's After-Market Session - Benzinga
PETS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
SLGB Stock Price and Chart — NASDAQ:SLGB - TradingView
Cellyan Biotechnology Co Ltd Stock (HKPD) Financials Data
There is no financial data for Cellyan Biotechnology Co Ltd (HKPD). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.79%
2.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):